| Financial Year |
March 31 2020 |
| Monetary Funds |
131,435,620.53 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
3,200,000.00 |
| Accounts Receivable |
24,300,739.48 |
| Advances to Suppliers |
17,659,079.33 |
| Other Receivables |
57,438,984.66 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
99,376,462.44 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
36,292,140.81 |
| Total Current Assets |
369,703,027.25 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
6,125,462.54 |
| Investment Properties |
-- |
| Fixed Assetes |
164,070,439.18 |
| Under-construction Projects |
102,726.42 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
53,537,996.12 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,749,538.59 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
227,586,162.85 |
| Total Assets |
597,289,190.10 |
| Short-Term Loans |
2,522,952,913.83 |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,470,000.00 |
| Accounts Payable |
712,305,974.18 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
73,200,805.38 |
| Taxes Payable |
26,199,080.07 |
| Interest Payable |
918,192,244.41 |
| Dividend Payable |
-- |
| Other payables |
1,454,153,655.77 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
4,350,000.00 |
| Other Current Liabilities |
1,355,000,000.00 |
| Sub-Total of Current Liabilities |
6,159,534,059.44 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
406,902,091.87 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
406,902,091.87 |
| Total Liabilities |
6,566,436,151.31 |
| Paid-In Capital(Or Share Stock) |
2,437,886,049.00 |
| Capital Surplus |
711,996,924.25 |
| Surplus Reserve |
52,945,092.56 |
| LESS:Treasury Stock |
309,418,701.50 |
| Undistributed Profits |
-8,901,779,124.78 |
| Minority Stockholder's Interest |
75,295,405.25 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-6,044,442,366.46 |
| Owner's Equity（Stockholder's Equity） |
-5,969,146,961.21 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
597,289,190.10 |
